Paper36683050
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
Ries A and 16 others. J Exp Clin Cancer Res, 2023. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. Papers, record 36683050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36683050
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesothelioma | Major topic |
| Mesothelioma, Malignant | Major topic |
| Humans | |
| Cisplatin | |
| Phosphatidylinositol 3-Kinases | |
| Wnt Signaling Pathway | |
| Comparative Genomic Hybridization | |
| Fibroblasts | |
| Cell Proliferation | |
| Cell Line, Tumor | |
| Tumor Microenvironment |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| I 3522 | Austrian Science Fund FWF | Austria | PubMed | |
| I 3977 | Austrian Science Fund FWF | Austria | PubMed | |
| I 4677 | Austrian Science Fund FWF | Austria | PubMed | |
| T 1062 | Austrian Science Fund FWF | Austria | PubMed |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17557954 | Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17557954 | PubMed |
| 2 | 19131956 | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. | Nat Protoc | 2009 | https://conductscience.org/library/papers/19131956 | PubMed |
| 3 | 16299245 | Inhibition of the met receptor in mesothelioma. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/16299245 | PubMed |
| 4 | 35462085 | Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations. | J Thorac Oncol | 2022 | https://conductscience.org/library/papers/35462085 | PubMed |
| 5 | 30715618 | Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics. | Curr Oncol Rep | 2019 | https://conductscience.org/library/papers/30715618 | PubMed |
| 6 | 14592528 | The mesothelial cell. | Int J Biochem Cell Biol | 2004 | https://conductscience.org/library/papers/14592528 | PubMed |
| 7 | 34624218 | Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. | Cancer Cell | 2021 | https://conductscience.org/library/papers/34624218 | PubMed |
| 8 | 33186182 | Malignant pleural mesothelioma: recent developments. | Curr Opin Oncol | 2021 | https://conductscience.org/library/papers/33186182 | PubMed |
| 9 | 33485464 | First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. | Lancet | 2021 | https://conductscience.org/library/papers/33485464 | PubMed |
| 10 | 34439349 | Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439349 | PubMed |
| 11 | 30734283 | In search of definitions: Cancer-associated fibroblasts and their markers. | Int J Cancer | 2020 | https://conductscience.org/library/papers/30734283 | PubMed |
| 12 | 21763682 | Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21763682 | PubMed |
| 13 | 34175688 | Wnt5a in cancer-associated fibroblasts promotes colorectal cancer progression. | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/34175688 | PubMed |
| 14 | 30868675 | Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30868675 | PubMed |
| 15 | 32705221 | Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma. | Oncol Rep | 2020 | https://conductscience.org/library/papers/32705221 | PubMed |
| 16 | 30190555 | High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform. | Nat Protoc | 2018 | https://conductscience.org/library/papers/30190555 | PubMed |
| 17 | 27683222 | 2016 update of the PRIDE database and its related tools. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27683222 | PubMed |
| 18 | 31533776 | Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/31533776 | PubMed |
| 19 | 25033209 | Quantitative and unbiased analysis of directional persistence in cell migration. | Nat Protoc | 2014 | https://conductscience.org/library/papers/25033209 | PubMed |
| 20 | 31887429 | Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas. | J Thorac Oncol | 2020 | https://conductscience.org/library/papers/31887429 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42864774 | Integrated scRNA-Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer-Associated Fibroblast-Dominant Domains in Colorectal Cancer. | Cancer Med | 2026 | https://conductscience.org/library/papers/42864774 | PubMed |
| 42737756 | Damage-Associated Molecular Patterns in Mesothelioma: Drivers of Inflammation and Therapeutic Targets. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737756 | PubMed |
| 42676823 | Multi-omics integration in malignant pleural mesothelioma: from molecular evolution and immune ecosystems to precision therapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42676823 | PubMed |
| 42000747 | Decoding the CAF-TAM axis: multi-omics dissection and therapeutic targeting of stromal-immune crosstalk in the tumor microenvironment. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42000747 | PubMed |
| 41826598 | Multi-omics integration reveals tumor and microenvironmental heterogeneity in malignant pleural mesothelioma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41826598 | PubMed |
| 41574700 | Deciphering the CAF‑LCN2 axis: Key to overcoming anti‑PD‑L1 immunotherapy resistance in lung cancer. | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41574700 | PubMed |
| 41428107 | A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41428107 | PubMed |
| 41390896 | Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer. | Br J Cancer | 2026 | https://conductscience.org/library/papers/41390896 | PubMed |
| 40656546 | Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40656546 | PubMed |
| 40626784 | Collisional Cross-Section Prediction for Multiconformational Peptide Ions with IM2Deep. | Anal Chem | 2025 | https://conductscience.org/library/papers/40626784 | PubMed |
| 39375726 | The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39375726 | PubMed |
| 39075165 | Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/39075165 | PubMed |
| 38791392 | Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791392 | PubMed |
| 38461268 | Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38461268 | PubMed |
| 38214315 | Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells. | Int J Oncol | 2024 | https://conductscience.org/library/papers/38214315 | PubMed |
| 38192631 | Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma. | Front Oncol | 2023 | https://conductscience.org/library/papers/38192631 | PubMed |
| 37938546 | Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37938546 | PubMed |
| 37566084 | Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. | Cells | 2023 | https://conductscience.org/library/papers/37566084 | PubMed |
Genes51
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36683050
GET https://conductscience.org/api/papers/v1/36683050/references?page=2